Physician profile
Patrick Terry Mangonon
NPI 1023067584
$41,641.16
in general payments reported to CMS, 2019-2025
31 companies · $5,535 in 2025
The $5,535 reported for 2025 was more than what 84% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,953 · 2020: $1,608 · 2021: $2,823 · 2022: $7,203 · 2023: $3,838 · 2024: $17K · 2025: $5,535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $13K · Food and Beverage: $6,025 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,000 · Travel and Lodging: $3,280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,750.00 |
| Food and Beverage | $6,024.61 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,000.00 |
| Travel and Lodging | $3,279.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $29,606.92 | 2019-2025 | Da Vinci Surgical System |
| Atricure, INC. | $4,576.43 | 2019-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System |
| Edwards Lifesciences Corporation | $2,654.42 | 2020-2025 | Mitris Resilia Mitral Valve, Evoque, Sapien 3 Ultra Resilia |
| Medtronic Vascular, INC. | $1,431.96 | 2019-2020 | |
| Abiomed | $606.75 | 2019-2025 | Impella |
| Cvrx, INC. | $538.75 | 2021-2025 | Barostim Neo System |
| Medtronic, INC. | $410.83 | 2021-2025 | Corevalve Evolut R, Aurora Ev-Icd Mri Surescan |
| Ethicon INC. | $280.05 | 2020-2021 | |
| Silk Road Medical, INC. | $269.62 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Astrazeneca Pharmaceuticals LP | $138.16 | 2023 | Tagrisso |
| Abbott Laboratories | $128.81 | 2019-2022 | |
| Dilon Technologies, INC. | $114.15 | 2023-2024 | Hemoblast Bellows |
| Cardiovascular Systems INC. | $112.13 | 2019-2020 | |
| Roche Diagnostics Corporation | $99.87 | 2019 | |
| Baxter Healthcare | $96.80 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $71.68 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $65.20 | 2024 | Keytruda |
| Getinge USA Sales, LLC | $59.25 | 2019-2024 | Acrobat-I Stabilizer, Vasoview Hemopro 2 |
| Veran Medical Technologies, INC. | $45.91 | 2020 | |
| Endologix LLC | $42.68 | 2019 | |
| Reel Surgical, INC. | $40.37 | 2023 | |
| Nuwellis, INC. | $38.18 | 2019 | |
| Covidien LP | $34.83 | 2020 | |
| Janssen Pharmaceuticals, INC | $31.36 | 2019 | |
| Ethicon US, LLC | $28.56 | 2022-2023 | Surgiflo Hemostatic Matrix, Ethicon, Vistaseal |
| Bolton Medical INC | $26.86 | 2019 | |
| Terumo Medical Corporation | $26.08 | 2019 | |
| Kls-Martin L.P. | $20.75 | 2019 | |
| Artivion, INC. | $15.48 | 2023 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Bioglue Surgical Adhesive, Cardiac Non-Synergraft |
| Teleflex LLC | $14.68 | 2020 | |
| Boston Scientific Corporation | $13.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Mangonon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.